Home » Newsletters » BioWorld Science

BioWorld Science

June 10, 2010

View Archived Issues

NicOx's NO-donating agents show preclinical promise in ophthalmology and pain

Serum bilirubin modulates response to bucindolol in patients with heart failure

Potent inhibitors identified of GIST-relevant kinases

Merck & Co. claims new cholesterol absorption inhibitors

Merck & Co. presents new sst5 receptor antagonists

NeuroSearch discovers new monoamine reuptake inhibitors

GlaxoSmithKline presents new AMPA receptor agonists

TransTech and Forest enter into agreement to develop GKAs

Vivalis and Sanofi Pasteur join to discover MAbs for infectious diseases

Nautilus Neurosciences launches Cambia for migraine in the U.S.

Simvastatin/ezetimibe combination promotes tumor growth in prostate cancer model

QBI-139 enters phase I trial in advanced/refractory solid tumors

Inhaled formoterol fumarate/glycopyrrolate is safe in healthy subjects

Protalix BioTherapeutics completes phase I trial of PRX-105

European Commission extends indication of RoActemra

Phase II data reported on IFN alpha-2b in patients with anogenital warts

Discovery receives FDA guidance for preclinical Surfaxin program in neonatal RDS

Idera reports preliminary phase I data on IMO-3100

Nektar Therapeutics reports phase II data on NKTR-102 in breast cancer

Aerovance presents phase IIb data on pitrakinra in eosinophilic asthma

NanoViricides' anti-HIV candidates efficacious against two HIV-1 isolates in vitro

Columbia Labs completes enrollment in phase III Prochieve trial

Eisai and Helsinn enter license agreement for antiemetic combination agent

Engrailed-2 proposed as diagnostic biomarker for prostate cancer

Phase III lubiprostone trial in idiopathic constipation complete

Eisai presents the year's product and financial highlights

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 23, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...